- Barrons.com•5 hours ago
Valeant Pharmaceuticals International (VRX) is scheduled to release its earnings next month, and investors will be looking for signs that its businesses are improving. RBC's Douglas Miehm and Joel Hurren ...
Valeant Pharmaceuticals International, Inc.NYSE
|Bid||23.26 x 500|
|Ask||23.27 x 900|
|52wk Range||18.55 - 263.81|
|Day's Range||22.82 - 23.37|
|Avg Vol (3m)||30,733,484|
As of 2:26 PM EDT. NYSE Real Time Price. Market open.